Wolverine Asset Management’s Emergent Biosolutions EBS Stock Holding History

Wolverine Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-51,400	Closed	-$2.08M	–	1479
2017 Q3	$2.08M	Sell	51,400 -80,000	-61%	-$2.89M	0.02%	475
2017 Q2	$4.46M	Buy	+131,400	New	+$4.06M	0.06%	260
2016 Q4	–	Sell	-25,000	Closed	-$788K	–	1209
2016 Q3	$788K	Sell	25,000 -87,300	-78%	-$2.54M	0.01%	614
2016 Q2	$3.16M	Buy	112,300 +112,096	+54,949%	+$4.39M	0.05%	344
2016 Q1	$41K	Buy	+204	New	+$7.21K	﹤0.01%	894

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Wolverine Asset Management's EBS Position: Q1 2026 in Review

Wolverine Asset Management held its Emergent Biosolutions (EBS) position steady in Q1 2026 at 174,933 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #674.

Wolverine Asset Management first reported a position in EBS in Q4 2017 and has held it in 13 quarters since. The position peaked at $2.16M in Q4 2025. 190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

Wolverine Asset Management held 174,933 shares of Emergent Biosolutions worth $1.45M as of Q1 2026.
Wolverine Asset Management left its Emergent Biosolutions share count unchanged in Q1 2026.
Emergent Biosolutions made up 0.01% of Wolverine Asset Management's portfolio in Q1 2026, its #674 holding.
Wolverine Asset Management first reported a position in Emergent Biosolutions in Q4 2017 and has held it in 13 quarters since.
Wolverine Asset Management's Emergent Biosolutions position peaked at $2.16M in Q4 2025.
190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Wolverine Asset Management's 13F filing for Q1 2026, filed 4 May 2026.